September 26, 2016
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Key Result
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are key pharmacological therapies updated in the 2016 ACC/AHA/HFSA guidelines for the management of heart failure.
Main Result
Absolute Event Rate: 0% vs 0%
Abstract
◼ angioedema ◼ angiotensin-converting enzyme inhibitors ◼ angiotensin receptor blockers ◼ angiotensin receptor
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
Clyde W. Yancy
Heart Failure & Transplant
Mariell Jessup
Heart Failure & Transplant
B
Biykem Bozkurt
American College of Cardiology
Journals
Circulation
Actions
Institutions
Stevenson University
Peterson (Norway)
Harry Gregg Foundation
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...